Ordering Recommendation
Not recommended.
Mnemonic
Methodology
Semi-Quantitative Chemiluminescent Immunoassay
Performed
Sun-Sat
Reported
Within 24 hours
New York DOH Approval Status
Specimen Required
CSF.
Transfer 0.5 mL CSF to an ARUP Standard Transport Tube. (Min: 0.3 mL)
Refrigerated. Also acceptable: Frozen.
Contaminated, heat-inactivated, hemolyzed, or xanthochromic specimens.
Ambient: 8 hours; Refrigerated: 2 weeks; Frozen: 1 year
Reference Interval
Effective August 20, 2012
8.9 AU/mL or less | Negative - No significant level of detectable IgG mumps virus antibody. |
9.0-10.9 AU/mL | Equivocal - Repeat testing in 10-14 days may be helpful. |
11.0 AU/mL or greater | Positive - IgG antibody to mumps virus detected, which may indicate a current or past mumps virus infection. |
Interpretive Data
The detection of antibodies to mumps virus in CSF may indicate central nervous system infection. However, consideration must be given to possible contamination by blood or transfer of serum antibodies across the blood-brain barrier.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Modified FDA
Note
Hotline History
CPT Codes
86735
Components
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
0054442 | Mumps Virus Antibody IgG CSF | 13266-2 |
Aliases
- CSF IgG Mumps
- Mumps Ab, IgG, CSF
- Mumps Abs CSF
- Mumps Antibodies, IgG